ABio Clinical Research Partners

03/13/2026

It's World Sleep Day! Along with some tips for better sleep, here are a couple companies to keep an eye on!
PAP User? Check out the SleepRes Kricket device: https://kricket.com/
Looking for alternative options? Learn about Cryosa: https://cryosa.com/

01/17/2026

ABio Clinical is excited to hear about the commercial launch of Kricket! Sleep Apnea sufferers - check it out!

Strong insights from David White, David White, M.D., Harvard Medical School, and chief medical officer of SleepRes™, Inc., in hi most recent HME News interview. As we prepares to commercialize Kricket™, powered by KPAP™, Dr. White explains why reducing inspiratory pressure and prioritizing how...

11/21/2025

Do you have an interest in participating in clinical trials? Follow us to learn more and stay tuned for upcoming studies!

11/09/2025

Have you ever been referred for an in-lab sleep study? Wouldn't it be more comfortable in your own home? Take a look at the latest Onera publication. ABio was able to conduct this study with the help of Clayton Sleep Institute and Sleep Disorders Center of Alabama. Conclusions: The device is a viable alternative to in-lab PSG, offering a user-friendly solution for comprehensive sleep assessment in a home setting.
https://rdcu.be/eO28J

08/08/2025

Some great data from the BELIEVE Study!

New research reveals that combining bimagrumab and semaglutide enhances fat loss while preserving muscle mass, revolutionizing obesity treatment strategies.

10/09/2024

Congratulations to the Emblok team for continued progress towards embolic protection. Database build powered by ABio in addition to site management and monitoring support. Excited to be a part of it!
https://www.prnewswire.com/news-releases/emblok-announces-enrollment-of-50th-patient-in-clinical-trial-for-emblok-embolic-protection-system-for-use-in-tavr-procedures-appoints-scientific-and-strategic-advisory-board-302269502.html?fbclid=IwY2xjawFzb8dleHRuA2FlbQIxMQABHeJRQBZAp6ujYo4JmxJkdciKsCkuVkS1Pg6SdHEVilWAR1MuvvT64DFuPQ_aem_Xq2bb0r0m8bo8pCuBucyFw

/PRNewswire/ -- EMBLOK™ (emblok.com), a privately held medical device company developing the most comprehensive next-generation embolic protection device to...

06/04/2024

Attending SLEEP 2024? Be sure to check out the following technology including a late breaking abstract authored by Clayton Sleep Institute and Andrea Brown.

Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced its presence at the upcoming SLEEP 2024 conference, the 3

03/15/2024

Who loves a good night of sleep?🙋‍♀️
And how many of us don't get enough?🙋
Probably most of us answered yes to both!
It's World Sleep Day and at ABio we have a lot of experience helping to bring new therapies to market. Today, we wanted to highlight a couple of our partners.
Follow Clayton Sleep Institute for some helpful tips from one of our Investigators, Dr. Joseph Ojile.
https://www.facebook.com/ClaytonSleepInstitute

Most people are familiar with CPAP or have heard of devices to treat sleep apnea. Have you seen some of the developments in groundbreaking pharmacologic research for OSA?
Check out Apnimed: https://apnimed.com/our-science/

Improving your life through better sleep

06/22/2023

Over 500 subjects enrolled and more than 170 here in the US!

/PRNewswire/ -- Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for obesity and other cardiometabolic...

03/15/2023

Did you know that it’s ? We have a team at ABio that loves sleep research! Apnimed is a company that’s worth watching. Learn more about what Apnimed is doing to potentially transform the treatment of , one of the most common and serious sleep disorders. http://ow.ly/MVfO50NgiAY.

At Apnimed, we are working to transform the treatment of obstructive sleep apnea (OSA) based on a simple idea – people with OSA could benefit from treatment with an oral medication. We are at the clinical trial stage of developing oral medications that address the disorder’s underlying neurobiol...

01/13/2023

Exciting news in the fight against obesity!

Transforming the treatment landscape for obesity and cardiometabolic diseases